Cargando…
A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis
It has been demonstrated conclusively that value and utility preference scores have only ordinal properties. This means, as has been pointed out on numerous occasions, that the quality adjusted life year (QALY) is a mathematically impossible construct. The implications are profound: Some 30 years of...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University of Minnesota Libraries Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401380/ https://www.ncbi.nlm.nih.gov/pubmed/36033108 http://dx.doi.org/10.24926/iip.v12i4.4329 |
_version_ | 1784772956379938816 |
---|---|
author | Langley, Paul C. |
author_facet | Langley, Paul C. |
author_sort | Langley, Paul C. |
collection | PubMed |
description | It has been demonstrated conclusively that value and utility preference scores have only ordinal properties. This means, as has been pointed out on numerous occasions, that the quality adjusted life year (QALY) is a mathematically impossible construct. The implications are profound: Some 30 years of health technology assessment is called into question due to a failure to recognize the well-documented limitations imposed by the axioms of fundamental measurement. The purpose of this commentary is provide a critical examination of this practice in recommendations for atopic dermatitis. |
format | Online Article Text |
id | pubmed-9401380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | University of Minnesota Libraries Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-94013802022-08-25 A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis Langley, Paul C. Innov Pharm Commentary It has been demonstrated conclusively that value and utility preference scores have only ordinal properties. This means, as has been pointed out on numerous occasions, that the quality adjusted life year (QALY) is a mathematically impossible construct. The implications are profound: Some 30 years of health technology assessment is called into question due to a failure to recognize the well-documented limitations imposed by the axioms of fundamental measurement. The purpose of this commentary is provide a critical examination of this practice in recommendations for atopic dermatitis. University of Minnesota Libraries Publishing 2021-09-22 /pmc/articles/PMC9401380/ /pubmed/36033108 http://dx.doi.org/10.24926/iip.v12i4.4329 Text en © Individual authors https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License, which permits noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Langley, Paul C. A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis |
title | A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis |
title_full | A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis |
title_fullStr | A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis |
title_full_unstemmed | A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis |
title_short | A Critical Examination of Simulation Pricing and Access Recommendations for Atopic Dermatitis |
title_sort | critical examination of simulation pricing and access recommendations for atopic dermatitis |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401380/ https://www.ncbi.nlm.nih.gov/pubmed/36033108 http://dx.doi.org/10.24926/iip.v12i4.4329 |
work_keys_str_mv | AT langleypaulc acriticalexaminationofsimulationpricingandaccessrecommendationsforatopicdermatitis AT langleypaulc criticalexaminationofsimulationpricingandaccessrecommendationsforatopicdermatitis |